Thermo Scientific™ DRI™ Fentanyl II Drugs of Abuse Assay

Specifically detect fentanyl and its primary metabolite, norfentanyl in urine using the Thermo Scientific™ DRI™ Fentanyl II drugs of abuse assay. This automated fentanyl urine drug screening test delivers quick and accurate preliminary results, enabling timely interventions for fentanyl abuse.

 

Supplier:  Thermo Scientific™ 10028871

Catalog No. 10-028-871

Description

Developed for hospital laboratories, addiction treatment centers, and toxicology laboratories, the Thermo Scientific™ DRI™ Fentanyl II Drugs of Abuse Assay is an effective tool for the screening fentanyl abuse and misuse. Its ability to detect both fentanyl and its primary metabolite, norfentanyl gives this assay a broader window of detection compared to competing products. This automated urine drug screening assay exhibits negligible cross-reactivity to other opioids. It is the only 510(k) cleared assay that combines norfentanyl cross-reactivity with a low 1 ng/mL cutoff concentration.

• Specifically detect fentanyl and its major metabolite, norfentanyl, at physiologically relevant concentrations in human urine 
• Low cross-reactivity to other non-fentanyl synthetic opioids and over-the-counter medication 
• High sensitivity with a cutoff concentration of 1 ng/mL 
• Superior assay precision 
• Excellent correlation to LC-MS/MS 
• Liquid, Ready-to-Use 

Specifications

• Content And Storage: 2°C to 8°C
• Description: DRI Fentanyl II Drugs of Abuse Assay  
• DoA Calibrators: DRI Fentanyl II DoA Assay
• Quantity: 1 x 500 mL 

• Control Sets: DRI Fentanyl II Control Kit
• Detectable Analytes: Fentanyl (FEN)
• Type: Reagent

For sale in the U.S.A. and Canada only.